June 23, 2025

TransMedics Group, Inc. (TMDX) Stock Analysis: A Promising 7.18% Upside with Innovative Organ Transplant Solutions

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the medical devices industry, is capturing investors’ attention with its innovative approach to organ transplant therapy. Headquartered in Andover, Massachusetts, this healthcare..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 20% Upside Potential Beckons Investors

Stevanato Group S.p.A. (NYSE: STVN), a prominent player in the healthcare sector, has captured investor attention with its robust growth potential and strong market positioning. Operating from its headquarters in..

Elanco Animal Health (ELAN): Investor Outlook Amidst Potential 10.43% Upside

Elanco Animal Health Incorporated (ELAN), a dedicated player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is capturing investors’ attention with its potential upside of..

Repligen Corporation (RGEN) Investor Outlook: Riding a Potential 54% Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN) stands out in the healthcare sector, particularly within the medical instruments and supplies industry, as a dynamic player in the bioprocessing technology space. With a market..

Prestige Consumer Healthcare (PBH) Stock Analysis: A 6% Potential Upside Amid Strong Revenue Growth

Prestige Consumer Healthcare Inc. (NYSE: PBH), a prominent player in the healthcare sector, is drawing investor attention with a potential upside of 6.06% as its stock price hovers at $83.44...

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech with 123.71% Potential Upside

For investors seeking opportunities in the biotechnology sector, Cytokinetics, Incorporated (NASDAQ: CYTK) presents a compelling case with its significant potential upside. The company, with a market capitalization of $3.87 billion,..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 32.78% Upside Potential

Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a formidable player in the healthcare sector, specifically within the medical devices industry. Headquartered in Hercules, California, the company has carved out a..

Waystar Holding Corp. (WAY) Stock Analysis: Exploring a 28% Upside Potential in the Healthcare Sector

Waystar Holding Corp. (NASDAQ: WAY) is making waves in the healthcare industry with its innovative cloud-based software solutions that streamline healthcare payments and financial management. As a key player in..

Ascendis Pharma A/S (ASND)

⚠️ No article content returned.

..

The Cooper Companies, Inc. (COO) Stock Analysis: A 36% Upside Potential with Strong Buy Ratings

The Cooper Companies, Inc. (NYSE: COO) is a prominent player in the healthcare sector, specializing in the medical instruments and supplies industry. With a market capitalization of $13.86 billion, this..

Akero Therapeutics, Inc. (AKRO) Investor Outlook: Exploring a 40% Upside Potential with Breakthrough Treatments

Akero Therapeutics, Inc. (NASDAQ: AKRO), a burgeoning name in the biotechnology sector, is capturing investor attention with its innovative approach to treating serious metabolic diseases. With a market capitalization of..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Exploring a 34.56% Potential Upside with Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing attention in the biotechnology sector with its focus on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, Rhythm Pharmaceuticals..

Soleno Therapeutics (SLNO) Stock Analysis: Unpacking the 38.78% Potential Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is capturing investor attention with a compelling 38.78% potential upside, reflecting a robust consensus among analysts. As a clinical-stage biopharmaceutical company, Soleno is primarily focused..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 34% Upside in the Biotech Revolution

For investors searching for promising opportunities in the biotechnology sector, BeOne Medicines Ltd. (ONC) stands out with a potential upside of 34.36% according to analyst ratings. Based in Basel, Switzerland,..

RadNet, Inc. (RDNT) Investor Outlook: Strong Buy Ratings and 29.59% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a prominent player in the healthcare sector, operates within the diagnostics and research industry, offering a diverse range of outpatient diagnostic imaging services. The company boasts..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: A Biotech Leader with 41% Upside Potential

BridgeBio Pharma, Inc. (BBIO) is making waves in the biotechnology sector with its innovative approach to treating genetic diseases and cancer. Headquartered in Palo Alto, California, the company has positioned..

BrightSpring Health Services (BTSG) Stock Analysis: A 22.57% Potential Upside in Healthcare Innovation

BrightSpring Health Services, Inc. (BTSG) is gaining attention in the healthcare sector with its robust service offerings and a promising potential upside of 22.57%. As a significant player in the..

Oscar Health, Inc. (OSCR) Stock Analysis: Assessing a 42.2% Revenue Growth in the Healthcare Plans Industry

Oscar Health, Inc. (NYSE: OSCR), a healthcare technology company, has been making waves in the healthcare plans industry with its innovative offerings and impressive revenue growth. Headquartered in New York,..

Bruker Corporation (BRKR): Investor Outlook on a 47% Potential Upside and Robust Revenue Growth

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, is making waves in the medical devices industry with its promising growth trajectory. Headquartered in Billerica, Massachusetts, Bruker specializes..

Alcon Inc. (ALC) Stock Analysis: Healthcare Giant Sees 23.88% Potential Upside

Alcon Inc. (NYSE: ALC), a prominent player in the global eye care industry, is drawing considerable attention from investors as it continues to exhibit steady growth in a challenging healthcare..

Search

Funds

June 23, 2025

Search

Funds

June 23, 2025

FTSE 100

Funds